Skopos Labs, Inc. Bei Gene, Ltd. Transaction History

Skopos Labs, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	N/A	967 Added 162.25%	1,563 $354,000
Q2 2025 Aug 14, 2025	BUY	N/A	349 Added 141.3%	596 $135,000
Q1 2025 May 13, 2025	BUY	$175.1 - $226.71 $36,595 - $47,382	209 Added 550.0%	247 $55,000
Q4 2024 Jan 15, 2025	BUY	$174.72 - $246.04 $6,639 - $9,349	38 New	38 $7,000

297

30.4M

147K

195K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

Stay updated on Skopos Labs, Inc. with notifications on news.